Lineage Cell Therapeutics, Inc.
LCTXLineage Cell Therapeutics, Inc. is a biotechnology company focused on developing innovative regenerative therapies using pluripotent and adult-derived cell technologies. The company aims to address unmet medical needs in areas such as neurodegenerative diseases, vision loss, and oncology by advancing the development of targeted cell-based treatments.
Company News
Cell-based therapies are emerging as a transformative approach in healthcare, with the global cell therapy market expected to grow from $4.7 billion in 2023 to over $20 billion by 2030. Several biotech companies announced significant milestones: Avaà Bio and Austrianova completed a Master Cell Bank for α-Klotho anti-aging therapy; Geron present...
The longevity biotech market is expanding rapidly, projected to grow from $9.86 billion in 2025 to $29.7 billion by 2034. Multiple companies are advancing cell and gene therapies targeting age-related diseases: Lineage Cell Therapeutics is developing islet therapy for Type 1 diabetes, Ocugen reported 46% lesion reduction in age-related macular de...
Avaà Bio announced it has initiated manufacturing of a Master Cell Bank of genetically modified cells that overexpress the α-Klotho protein, a key anti-aging protein that naturally declines by 50% after age 40. The milestone represents a transition from research to production infrastructure for their Klothonova anti-aging platform using Cell-in...
The healthcare sector is experiencing a structural shift toward regenerative medicine and longevity infrastructure, valued at $27 trillion by 2030. Several biotech companies are advancing cell therapy and gene-targeted treatments: Avant Technologies presented cell encapsulation technology for diabetes at a European symposium, MannKind received FD...
W.P. Carey, a diversified net lease REIT, reported Q2 2025 earnings with strong revenue growth and AFFO per share, despite experiencing net income decline due to non-cash market adjustments. The company raised full-year guidance and increased quarterly dividend.
